Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: results of the Health, Health Care and Insurance Survey, 2012

Publié le 1 Avril 2017
Mis à jour le 10 septembre 2019

Background: in France, human papillomavirus (HPV) vaccination coverage among adolescents and young women is low and decreasing. We analysed data from the 2012 Health, Health Care and Insurance Survey with the aim of identifying factors associated with this vaccination. We also compared the socioeconomic profile of unvaccinated young women to that of women who do not undergo cervical cancer screening (CCS). Methods: data were collected through interviews and self-administered questionnaires completed by a randomised sample of Health insurance beneficiaries. Two analyses were performed using Poisson regression: one to investigate the determinants of CCS uptake in women aged 25 65 years old (n = 4508), the other to investigate the determinants of HPV vaccination in young women aged 16 24 years old (n = 899). A sub-analysis was performed in 685 "daughter mother" couples from the same household in order to analyse the association between participation to CCS in mothers and HPV vaccination in daughters. Results: factors significantly associated both to a lower CCS uptake and to an insufficient HPV vaccination were the lack of a complementary private health insurance (P = 0.023 and P = 0.037, respectively) and living in a family with a low household income (P < 0.001 and P = 0.005, respectively). A low education level was associated to a lower CCS uptake (P < 0.001). The absence of CCS uptake in the last three years in mothers was associated to a lower level of HPV vaccination in their daughter (P = 0.014). Conclusion: women who do not undergo CCS and HPV unvaccinated young women tend to be of modest socioeconomic status. Unvaccinated young females tend to have mothers who do not undergo CCS and are therefore at risk of benefiting from none of the two cervical cancer preventive measures. The current implementation strategy concerning HPV vaccination in France may therefore increase inequalities regarding cervical cancer prevention.

Auteur : Guthmann JP, Pelat C, Celant N, Parent du Chatelet I, Duport N, Rochereau T, Levy Bruhl D
Revue d'épidémiologie et de santé publique, 2017, vol. 65, n°. 2, p. 109-17